Hypothetical dopamine dynamics in mania and psychosis - its pharmacokinetic implications

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 43, Issue , 2013, Pages 89-95

  Park, Seo Yeon ^a   Kang, Ung Gu ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Antipsychotics; Dopamine; Koff; Mania; Psychosis; Simulation

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR; NEUROLEPTIC AGENT;

ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; HYPOTHESIS; MANIA; PSYCHOSIS; RECEPTOR OCCUPANCY; SIMULATION;

ANIMALS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; COCAINE; DOPAMINE; DOPAMINERGIC NEURONS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGICAL PHENOMENA; EXTRACELLULAR SPACE; MOTOR ACTIVITY; PSYCHOTIC DISORDERS; RATS; RECEPTORS, DOPAMINE D2; SIGNAL TRANSDUCTION;

EID: 84872400381     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.12.014     Document Type: Article

References (33)

1. Agrawal A., Nurnberger J.I., Lynskey M.T. Item response modeling of DSM-IV mania symptoms in two representative US epidemiological samples. Psychol Med 2010, 40:1549-1558.
2. Andreasen N.C. Thought, language, and communication disorders. I. Clinical assessment, definition of terms, and evaluation of their reliability. Arch Gen Psychiatry 1979, 36:1315-1321.
3. Andreasen N.C., Grove W.M. Thought, language, and communication in schizophrenia: diagnosis and prognosis. Schizophr Bull 1986, 12:348-359.
4. Bergman A., O'brien J., Osgood G., Cornblatt B. Distractibility in schizophrenia. Psychiatry Res 1995, 57:131-140.
5. Cipriani A., Barbui C., Salanti G., Rendell J., Brown R., Stockton S., et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet 2011, 378:1306-1315.
6. Cuesta M.J., Peralta V. Testing the hypothesis that formal thought disorders are severe mood disorders. Schizophr Bull 2011, 37:1136-1146.
7. Dreyer J.K., Herrik K.F., Berg R.W., Hounsgaard J.D. Influence of phasic and tonic dopamine release on receptor activation. J Neurosci 2010, 30:14273-14283.
8. Gao K., Ganocy S.J., Gajwani P., Muzina D.J., Kemp D.E., Calabrese J.R. A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence. J Clin Psychiatry 2008, 69:302-309.
9. Grace A.A., Bunney B.S. The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 1984, 4:2877-2890.
10. Howes O.D., Kapur S. The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophr Bull 2009, 35:549-562.
11. Hurd Y.L., Ungerstedt U. Cocaine: an in vivo microdialysis evaluation of its acute action on dopamine transmission in rat striatum. Synapse 1989, 3:48-54.
12. Johanson C.E., Uhlenhuth E.H. Drug preference and mood in humans: d-amphetamine. Psychopharmacology (Berl) 1980, 71:275-279.
13. John C.E., Jones S.R. Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices. Neuropharmacology 2007, 52:1596-1605.
14. Kang U.G. What are the optimal pharmacokinetic properties of antipsychotic medications?. Prog Neuropsychopharmacol Biol Psychiatry 2012, 36:117-121.
15. Kapur S., Seeman P. Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action. J Psychiatry Neurosci 2000, 25:161-166.
16. Lau C.E., Imam A., Ma F., Falk J.L. Acute effects of cocaine on spontaneous and discriminative motor functions: relation to route of administration and pharmacokinetics. J Pharmacol Exp Ther 1991, 257:444-456.
17. Lieberman J.A., Sheitman B.B., Kinon B.J. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology 1997, 17:205-229.
18. Lyon M. Animal models for the symptoms of mania. Animal models in psychiatry, I 1991, 197-244. Humana Press, [Place]. A.A. Boulton, G.B. Baker, M.T. Martin-Iverson (Eds.).
19. Martin-Iverson M.T. An animal model of stimulant psychosis. Animal models in psychiatry, I 1991, 103-149. Humana Press, [Place]. A.A. Boulton, G.B. Baker, M.T. Martin-Iverson (Eds.).
20. Miller R. Schizophrenic psychology, associative learning and the role of forebrain dopamine. Med Hypotheses 1976, 2:203-211.
21. Panksepp J. Seeking systems and anticipatory states of the nervous system. Affective neuroscience 1998, 144-163. Oxford Univ Press, [Place].
22. Pettit H.O., Justice J.B. Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis. Pharmacol Biochem Behav 1989, 34:899-904.
23. Pierce R.C., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 1997, 25:192-216.
24. Post R.M., Rose H. Increasing effects of repetitive cocaine administration in the rat. Nature 1976, 260:731-732.
25. Rice M.E., Cragg S.J. Dopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathway. Brain Res Rev 2008, 58:303-313.
26. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993, 18:247-291.
27. Salimpoor V.N., Benovoy M., Larcher K., Dagher A., Zatorre R.J. Anatomically distinct dopamine release during anticipation and experience of peak emotion to music. Nat Neurosci 2010, 14:257-262.
28. Schultz W., Dayan P., Montague P.R. A neural substrate of prediction and reward. Science 1997, 275:1593-1599.
29. Seeman P. All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2 receptors. CNS Neurosci Ther 2011, 17:118-132.
30. Silverstone T., Wells B., Trenchard E. Differential dose-response effects of dexamphetamine sulphate on hunger, arousal and mood in human volunteers. Psychopharmacology (Berl) 1983, 79:242-245.
31. Ujike H., Sato M. Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Ann N Y Acad Sci 2004, 1025:279-287.
32. Venton B.J., Zhang H., Garris P.A., Phillips P.E., Sulzer D., Wightman R.M. Real-time decoding of dopamine concentration changes in the caudate-putamen during tonic and phasic firing. J Neurochem 2003, 87:1284-1295.
33. Zhornitsky S., Potvin S., Moteshafi H., Dubreucq S., Rompre P.P., Stip E. Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders: a systematic review of the placebo-controlled monotherapy and add-on trials. Int Clin Psychopharmacol 2011, 26:183-192.